 |
|
Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis
Sanaa Ben Djemaa
1
Stéphanie David
1, *
Katel Hervé-Aubert
1
Annarita Falanga
2
Stefania Galdiero
3
Émilie Allard-Vannier
1
Igor Chourpa
1
Emilie Munnier
1
*
Corresponding author
Sanaa Ben Djemaa 1
Author
Stéphanie David 1
Mail :
Correspondent author
Katel Hervé-Aubert 1
Author
Annarita Falanga 2
Author
Stefania Galdiero 3
Mail :
Author
Émilie Allard-Vannier 1
Author
Igor Chourpa 1
Mail :
Author IdHAL : igor-chourpa
Emilie Munnier 1
Mail :
Author
1
NMNS - Nanomédicaments et Nanosondes, EA 6295 (Faculté de pharmacie
31 avenue Monge
37200 Tours - France)
- Université de Tours (60 rue du Plat d'Étain, 37020 Tours cedex 1 - France)
2
Department of Pharmacy and CIRPeB (Via Mezzocannone 16, 80134 Naples - Italy)
3
Department of Pharmacy and CIRPeB (Via Mezzocannone, 16 80134 Naples, Italy - Italy)
- University of Naples Federico II (Italy)
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-tours.archives-ouvertes.fr/hal-01919906
Contributor : Martin Soucé <>
Submitted on : Monday, November 12, 2018 - 5:58:36 PM
Last modification on : Thursday, November 14, 2019 - 10:46:06 AM
Contributor : Martin Soucé <>
Submitted on : Monday, November 12, 2018 - 5:58:36 PM
Last modification on : Thursday, November 14, 2019 - 10:46:06 AM
Identifiers
- HAL Id : hal-01919906, version 1
- DOI : 10.1016/j.ejpb.2018.07.024
Collections
Citation
Sanaa Ben Djemaa, Stéphanie David, Katel Hervé-Aubert, Annarita Falanga, Stefania Galdiero, et al.. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis. European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2018, 131, pp.99 - 108. ⟨10.1016/j.ejpb.2018.07.024⟩. ⟨hal-01919906⟩
Metrics
Record views
